{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:43:16Z","timestamp":1792633396651,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T00:00:00Z","timestamp":1605225600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Acute ischemic stroke (AIS) is one of the leading causes of mortality and long-term disability worldwide. Our study aims to clarify the role of low-density lipoproteins (LDL) subclasses in the occurrence of AIS and develop a risk xprediction model based on these characteristics to identify high-risk people.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Five hundred and sixty-six patients with AIS and 197 non-AIS controls were included in this study. Serum lipids and other baseline characteristics including fasting blood glucose (GLU), serum creatinine (Scr), and blood pressure were investigated in relation to occurrence of AIS. The LDL subfractions were classified and measured with the Lipoprint System by a polyacrylamide gel electrophoresis technique.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Levels of LDL-3, LDL-4 and LDL-5 subclasses were significantly higher in the AIS group compared to the non-AIS group and lower level of LDL-1 was prevalent in the AIS patients. Consistently, Spearman correlation coefficient demonstrated that sd-demonevels, especially LDL-3 and LDL-4 levels, were significantly positively correlated with AIS. Furthermore, there is a significant positive correlation between small dense LDL (sd-LDL, that is LDL-3 to 7) levels and serum lipids including total cholesterol (TC), Low density lipoprotein cholesterol (LDL-C), and Triglyceride (TG). Increased LDL-3 and LDL-4 as well as decreased LDL-1 and LDL-2 were correlated to the occurrence of AIS, even in the people with normal LDL-C levels. A new prediction model including 12 variables can accurately predict the AIS risk in Chinese patients (AUC\u2009=\u20090.82\u2009\u00b1\u20090.04).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Levels of LDL subclasses should be considered in addition to serum LDL-C in assessment and management of AIS. A new prediction model based on clinical variables including LDL subtractions can help clinicians identify high of AIS, even in the people with norm.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-020-01989-6","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T23:50:09Z","timestamp":1605225009000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Estimation of the LDL subclasses in ischemic stroke as a risk factor in a Chinese population"],"prefix":"10.1186","volume":"20","author":[{"given":"Ruisheng","family":"Duan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4260-9231","authenticated-orcid":false,"given":"Wenjun","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunpeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongshan","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Diao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,13]]},"reference":[{"issue":"25","key":"1989_CR1","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.1056\/NEJMoa1804492","volume":"379","author":"VL Feigin","year":"2018","unstructured":"Collaborators GBDLRoS, Feigin VL, Nguyen G, Cercy K, Johnson CO, Alam T, et al. Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016. N Engl J Med. 2018;379(25):2429\u201337. https:\/\/doi.org\/10.1056\/NEJMoa1804492.","journal-title":"N Engl J Med"},{"issue":"1\u20132","key":"1989_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jns.2008.12.012","volume":"279","author":"HS Kirshner","year":"2009","unstructured":"Kirshner HS. Differentiating ischemic stroke subtypes: risk factors and secondary prevention. J Neurol Sci. 2009;279(1\u20132):1\u20138. https:\/\/doi.org\/10.1016\/j.jns.2008.12.012.","journal-title":"J Neurol Sci"},{"issue":"8","key":"1989_CR3","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1161\/01.STR.0000079818.08343.8C","volume":"34","author":"UG Schulz","year":"2003","unstructured":"Schulz UG, Rothwell PM. Differences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studies. Stroke. 2003;34(8):2050\u20139. https:\/\/doi.org\/10.1161\/01.STR.0000079818.08343.8C.","journal-title":"Stroke."},{"issue":"6","key":"1989_CR4","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1111\/j.1365-2265.2008.03407.x","volume":"70","author":"M Rizzo","year":"2009","unstructured":"Rizzo M, Pernice V, Frasheri A, Di Lorenzo G, Rini GB, Spinas GA, et al. Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome. Clin Endocrinol. 2009;70(6):870\u20135. https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03407.x.","journal-title":"Clin Endocrinol"},{"issue":"8","key":"1989_CR5","doi-asserted-by":"publisher","first-page":"e179","DOI":"10.1515\/cclm-2012-0737","volume":"51","author":"HJ Huh","year":"2013","unstructured":"Huh HJ, Park BT, Lee SY, Kang ES, Park HD. Establishing reference intervals for LDL subfractions in a Korean population using the Lipoprint LDL system. Clin Chem Lab Med. 2013;51(8):e179\u201382. https:\/\/doi.org\/10.1515\/cclm-2012-0737.","journal-title":"Clin Chem Lab Med"},{"issue":"25","key":"1989_CR6","doi-asserted-by":"publisher","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","volume":"106","author":"National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A","year":"2002","unstructured":"National Cholesterol Education Program Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143\u2013421.","journal-title":"Circulation"},{"issue":"2","key":"1989_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/clinchem\/47.2.266","volume":"47","author":"DM Hoefner","year":"2001","unstructured":"Hoefner DM, Hodel SD, O'Brien JF, Branum EL, Sun D, Meissner I, et al. Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL system. Clin Chem. 2001;47(2):266\u201374.","journal-title":"Clin Chem"},{"issue":"12","key":"1989_CR8","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1007\/s11745-011-3611-8","volume":"46","author":"KA Varady","year":"2011","unstructured":"Varady KA, Lamarche B. Lipoprint adequately estimates LDL size distribution, but not absolute size, versus polyacrylamide gradient gel electrophoresis. Lipids. 2011;46(12):1163\u20137. https:\/\/doi.org\/10.1007\/s11745-011-3611-8.","journal-title":"Lipids."},{"key":"1989_CR9","doi-asserted-by":"publisher","unstructured":"Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2019. https:\/\/doi.org\/10.1016\/S0140-6736(19)30427-1.","DOI":"10.1016\/S0140-6736(19)30427-1"},{"issue":"3","key":"1989_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3349\/ymj.2006.47.3.405","volume":"47","author":"SW Kwon","year":"2006","unstructured":"Kwon SW, Yoon SJ, Kang TS, Kwon HM, Kim JH, Rhee J, et al. Significance of small dense low-density lipoprotein as a risk factor for coronary artery disease and acute coronary syndrome. Yonsei Med J. 2006;47(3):405\u201314. https:\/\/doi.org\/10.3349\/ymj.2006.47.3.405.","journal-title":"Yonsei Med J"},{"issue":"1","key":"1989_CR11","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2005.12.002","volume":"189","author":"S Koba","year":"2006","unstructured":"Koba S, Hirano T, Ito Y, Tsunoda F, Yokota Y, Ban Y, et al. Significance of small dense low-density lipoprotein-cholesterol concentrations in relation to the severity of coronary heart diseases. Atherosclerosis. 2006;189(1):206\u201314. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2005.12.002.","journal-title":"Atherosclerosis."},{"issue":"1","key":"1989_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2007.03.034","volume":"197","author":"M Rizzo","year":"2008","unstructured":"Rizzo M, Pernice V, Frasheri A, Berneis K. Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease. Atherosclerosis. 2008;197(1):237\u201341. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2007.03.034.","journal-title":"Atherosclerosis."},{"issue":"6","key":"1989_CR13","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1111\/ggi.13287","volume":"18","author":"K Sakai","year":"2018","unstructured":"Sakai K, Koba S, Nakamura Y, Yokota Y, Tsunoda F, Shoji M, et al. Small dense low-density lipoprotein cholesterol is a promising biomarker for secondary prevention in older men with stable coronary artery disease. Geriatr Gerontol Int. 2018;18(6):965\u201372. https:\/\/doi.org\/10.1111\/ggi.13287.","journal-title":"Geriatr Gerontol Int"},{"issue":"7","key":"1989_CR14","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/1354750X.2018.1474256","volume":"23","author":"X Zhao","year":"2018","unstructured":"Zhao X, Sun D, Xu RX, Guo YL, Zhu CG, Wu NQ, et al. Low-density lipoprotein-associated variables and the severity of coronary artery disease: an untreated Chinese cohort study. Biomarkers. 2018;23(7):647\u201353. https:\/\/doi.org\/10.1080\/1354750X.2018.1474256.","journal-title":"Biomarkers."},{"issue":"11","key":"1989_CR15","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1080\/03007995.2017.1365052","volume":"33","author":"R Chaudhary","year":"2017","unstructured":"Chaudhary R, Mathew D, Bliden K, Tantry US, Sharma T, Gesheff MG, et al. Low-density lipoprotein 4: a novel predictor of coronary artery disease severity. Curr Med Res Opin. 2017;33(11):1979\u201384. https:\/\/doi.org\/10.1080\/03007995.2017.1365052.","journal-title":"Curr Med Res Opin"},{"issue":"2","key":"1989_CR16","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.atherosclerosis.2009.11.040","volume":"210","author":"A Zeljkovic","year":"2010","unstructured":"Zeljkovic A, Vekic J, Spasojevic-Kalimanovska V, Jelic-Ivanovic Z, Bogavac-Stanojevic N, Gulan B, et al. LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality. Atherosclerosis. 2010;210(2):548\u201354. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2009.11.040.","journal-title":"Atherosclerosis."},{"issue":"1","key":"1989_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5152\/npa.2017.19393","volume":"56","author":"Y Kayran","year":"2019","unstructured":"Kayran Y, Yayla V, Cabalar M, Bajrami A, Karamanli Y, Gedikbasi A, et al. LDL subclasses in ischemic stroke: a risk factor? Noro Psikiyatr Ars. 2019;56(1):13\u20137. https:\/\/doi.org\/10.5152\/npa.2017.19393.","journal-title":"Noro Psikiyatr Ars"},{"issue":"1","key":"1989_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0005-2760(88)90002-1","volume":"960","author":"DW Swinkels","year":"1988","unstructured":"Swinkels DW, Demacker PN, Hak-Lemmers HL, Mol MJ, Yap SH, van't Laar A. Some metabolic characteristics of low-density lipoprotein subfractions, LDL-1 and LDL-2: in vitro and in vivo studies. Biochim Biophys Acta. 1988;960(1):1\u20139. https:\/\/doi.org\/10.1016\/0005-2760(88)90002-1.","journal-title":"Biochim Biophys Acta"},{"issue":"10","key":"1989_CR19","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1007\/s11745-012-3706-x","volume":"47","author":"S Yazdandoust","year":"2012","unstructured":"Yazdandoust S, Parizadeh SM, Moohebati M, Yaghmaei P, Rahsepar AA, Tavallaie S, et al. Serum small dense low-density lipoprotein concentrations are elevated in patients with significant coronary artery stenosis and are related to features of the metabolic syndrome. Lipids. 2012;47(10):963\u201372. https:\/\/doi.org\/10.1007\/s11745-012-3706-x.","journal-title":"Lipids."},{"issue":"9735","key":"1989_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","volume":"376","author":"MJ O'Donnell","year":"2010","unstructured":"O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet. 2010;376(9735):112\u201323. https:\/\/doi.org\/10.1016\/S0140-6736(10)60834-3.","journal-title":"Lancet."},{"issue":"3","key":"1989_CR21","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1161\/01.str.28.3.557","volume":"28","author":"SG Wannamethee","year":"1997","unstructured":"Wannamethee SG, Shaper AG, Perry IJ. Serum creatinine concentration and risk of cardiovascular disease: a possible marker for increased risk of stroke. Stroke. 1997;28(3):557\u201363. https:\/\/doi.org\/10.1161\/01.str.28.3.557.","journal-title":"Stroke."},{"issue":"4","key":"1989_CR22","doi-asserted-by":"publisher","first-page":"e0215134","DOI":"10.1371\/journal.pone.0215134","volume":"14","author":"X Luo","year":"2019","unstructured":"Luo X, Lin F, Zhu S, Yu M, Zhang Z, Meng L, et al. Mine landslide susceptibility assessment using IVM, ANN and SVM models considering the contribution of affecting factors. PLoS One. 2019;14(4):e0215134. https:\/\/doi.org\/10.1371\/journal.pone.0215134.","journal-title":"PLoS One"},{"issue":"1","key":"1989_CR23","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12967-019-1860-0","volume":"17","author":"J Xiao","year":"2019","unstructured":"Xiao J, Ding R, Xu X, Guan H, Feng X, Sun T, et al. Comparison and development of machine learning tools in the prediction of chronic kidney disease progression. J Transl Med. 2019;17(1):119. https:\/\/doi.org\/10.1186\/s12967-019-1860-0.","journal-title":"J Transl Med"},{"key":"1989_CR24","doi-asserted-by":"publisher","unstructured":"Kilic A, Goyal A, Miller JK, Gleason TG, Dubrawksi A. Performance of a machine learning algorithm in predicting outcomes of aortic valve replacement. Ann Thorac Surg. 2020. https:\/\/doi.org\/10.1016\/j.athoracsur.2020.05.107.","DOI":"10.1016\/j.athoracsur.2020.05.107"},{"issue":"4","key":"1989_CR25","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1093\/bioinformatics\/btz734","volume":"36","author":"B Yu","year":"2020","unstructured":"Yu B, Qiu W, Chen C, Ma A, Jiang J, Zhou H, et al. SubMito-XGBoost: predicting protein submitochondrial localization by fusing multiple feature information and eXtreme gradient boosting. Bioinformatics. 2020;36(4):1074\u201381. https:\/\/doi.org\/10.1093\/bioinformatics\/btz734.","journal-title":"Bioinformatics."}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01989-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12883-020-01989-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-020-01989-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T23:50:26Z","timestamp":1605225026000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-020-01989-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,13]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1989"],"URL":"https:\/\/doi.org\/10.1186\/s12883-020-01989-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-65582\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-65582\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-65582\/v3","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,13]]},"assertion":[{"value":"24 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans, and the protocol was approved by the Ethics Committee of Hebei General Hospital, the First People\u2019s Hospital of Pingdingshan and the Affiliated Hospital of Chengde Medical University. Informed consent was obtained for experimentation with human subjects. Every individual was informed about the aims of the study and provided written consent before participation. Written informed consent was obtained from a relative in the case of patients with impaired cognition.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"414"}}